These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 890435)

  • 21. [Therapy of psychosomatic pathology of the digestive tract with a combination of nortriptyline and fluphenazine].
    Sarti F; D'Imperio N; Milandri M; Soffritti M; Spongano P; Blotta A; Dal Monte PR
    Clin Ter; 1977 Mar; 80(6):537-44. PubMed ID: 862354
    [No Abstract]   [Full Text] [Related]  

  • 22. Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr. level in depressed patients.
    Brunswick DJ; Amsterdam J; Schless A; Rothbart M; Sandler K; Mendels J
    J Clin Psychiatry; 1980 Oct; 41(10):337-40. PubMed ID: 7430077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
    Lydiard RB
    J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of individual dosage of nortriptyline in depressed elderly outpatients.
    Schneider LS; Cooper TB; Staples FR; Sloane RB
    J Clin Psychopharmacol; 1987 Oct; 7(5):311-4. PubMed ID: 3680600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders.
    Corona GL; Pinelli P; Zerbi F; Fenoglio L; Santagostino G; Frattini P; Cucchi ML
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):102-10. PubMed ID: 7393996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
    Vandel S; Bertschy G; Jounet JM; Allers G
    Ther Drug Monit; 1988; 10(4):386-9. PubMed ID: 3144066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The measurement of plasma levels of tricyclic antidepressant drugs.
    Scoggins BA; Coghlan JP; Maguire K; Burrows GD; Davies B
    Aust N Z J Psychiatry; 1976 Mar; 10(1):7-12. PubMed ID: 1065320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.
    Alexanderson B; Evans DA; Sjöqvist F
    Br Med J; 1969 Dec; 4(5686):764-8. PubMed ID: 5391106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.
    Koreen AR; Lieberman J; Alvir J; Chakos M; Loebel A; Cooper T; Kane J
    Am J Psychiatry; 1994 Jan; 151(1):35-9. PubMed ID: 8267132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Child and adolescent nortriptyline single dose kinetics predict steady state plasma levels and suggested dose: preliminary data.
    Geller B; Cooper TB; Chestnut EC; Anker JA; Price DT; Yates E
    J Clin Psychopharmacol; 1985 Jun; 5(3):154-8. PubMed ID: 3998205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzodiazepines and tricyclic antidepressant plasma levels.
    Silverman G; Braithwaite RA
    Br Med J; 1973 Jul; 3(5870):18-20. PubMed ID: 4717418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma prolactin during treatment with nortriptyline.
    Nielsen JL
    Neuropsychobiology; 1980; 6(1):52-5. PubMed ID: 7366815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiety/depression in elderly patients. A double-blind comparative study of fluphenazine/nortriptyline and promazine.
    Brodie NH; McGhie RL; O'Hara H; Valle-Jones JC; Schiff AA
    Practitioner; 1975 Nov; 215(1289):660-4. PubMed ID: 1105543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting therapeutic plasma levels of nortriptyline from test dose plasma concentrations.
    Clothier J; Reed K
    J Clin Psychopharmacol; 1984 Aug; 4(4):216-7. PubMed ID: 6470195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A radioimmunoassay for the determination of combined amitriptyline and nortriptyline concentrations in microliter samples of plasma.
    Robinson JD; Risby D; Riley G; Aherne GW
    J Pharmacol Exp Ther; 1978 May; 205(2):499-502. PubMed ID: 641845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between plasma level and therapeutic effect of nortriptyline.
    Asberg M; Crönholm B; Sjöqvist F; Tuck D
    Br Med J; 1971 Aug; 3(5770):331-4. PubMed ID: 5558186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CASTLE analysis finds no benefit for once daily dosing.
    Proj Inf Perspect; 2008 Dec; (47):4. PubMed ID: 19226675
    [No Abstract]   [Full Text] [Related]  

  • 38. Amitriptyline dosage prediction in elderly patients from plasma concentration at 24 hours after a single 100mg dose.
    Dawling S; Ford S; Rangedara DC; Lewis RR
    Clin Pharmacokinet; 1984; 9(3):261-6. PubMed ID: 6734015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Once a day is best: evidence or assumption? The relationship between compliance and dosage frequency in older people.
    Pushpangadan M; Feely M
    Drugs Aging; 1998 Sep; 13(3):223-7. PubMed ID: 9789726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
    Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
    J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.